Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia
A phase 3 trial of Filgrastim, Amsacrine, Carmustine, Cytarabine, Etoposide, Idarubicin and Mitoxantrone in Leukaemia, run by European Organisation for Research and Treatment of Cancer - EORTC, completed.
Overview
Combination Chemotherapy With or Without G-CSF in Treating Older Patients With Acute Myeloid Leukemia is a phase 3 interventional study registered as NCT00002719 by European Organisation for Research and Treatment of Cancer - EORTC, with 500 participants recorded, started 1995-12 and reaching its primary completion in 2001-11. Interventions recorded: filgrastim, amsacrine, carmustine, cytarabine, etoposide, idarubicin, mitoxantrone hydrochloride, peripheral blood stem cell transplantation. Conditions recorded: Leukemia, Neutropenia.
Linked to the drug Amsacrine because the registry names it among its interventions and Leukaemia among its conditions. Registry record only: no result has been read by an editor.
Similar pages
not linked directly; found by shared links- TrialCombination Chemotherapy, Biological Therapy, and Bone Marrow Transplantation in Treating Patients With Acute Myeloid Leukemia
Shares Amsacrine, Idarubicin, Mitoxantrone, Filgrastim (G-CSF) and the tag pipeline.
- TrialCombination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
Shares Amsacrine, Mitoxantrone, Cytarabine, Leukaemia (all types) and the tag pipeline.
- TrialTreatment of Patients With Newly Diagnosed Acute Myeloid Leukemia or Myelodysplasia
Shares Mitoxantrone, Cytarabine, Leukaemia (all types), Etoposide and the tag pipeline.
- TrialResponse-Based Chemotherapy in Treating Newly Diagnosed Acute Myeloid Leukemia or Myelodysplastic Syndrome in Younger Patients With Down Syndrome
Shares Mitoxantrone, Cytarabine, Leukaemia (all types), Etoposide and the tag pipeline.
- TrialA Global Study of Midostaurin in Combination With Chemotherapy to Evaluate Safety, Efficacy and Pharmacokinetics in Newly Diagnosed Pediatric Patients With FLT3 Mutated AML
Shares Idarubicin, Mitoxantrone, Cytarabine and the tag pipeline.
- TrialA Study of ASP2215 Versus Salvage Chemotherapy In Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML) With FMS-like Tyrosine Kinase 3 (FLT3) Mutation
Shares Mitoxantrone, Cytarabine, Etoposide and the tag pipeline.
- TrialCombination Chemotherapy With or Without Lestaurtinib in Treating Younger Patients With Newly Diagnosed Acute Lymphoblastic Leukemia
Shares Filgrastim (G-CSF), Cytarabine, Leukaemia (all types), Etoposide and the tag pipeline.
- TrialPhase 2 Trial of Prophylactic Rituximab Therapy for Prevention of CGVHD
Shares Filgrastim (G-CSF), Leukaemia (all types) and the tag pipeline.